Insufficient evidence / under studyEgradePlausibility · Microcurrent delivery plausible at TENS level (cleared for pain only); the 'quantum sensor' frequencyElectroceuticals / Bioelectronic Medicine
Split the claims. The microcurrent output is real, TENS-level hardware with a narrow US clearance; the 'quantum sensor' that individualises 'frequencies' is a separate doctrine that contradicts established science. The clearance covers the microcurrent component only — clearance, never approval.
Enforcement & provenance — Australia (TGA): Healy World Australia Pty Ltd was fined AU$26,640 on 2022-03-03 for advertising the TENS device outside its ARTG purpose while referencing serious conditions. This is an enforcement fact and does not move the tier. Source: tga.gov.au media release, 2022-03-03.
Origin & lineage
Healy World (Germany), 2019–.
Claimed mechanism
Delivers microcurrent while a 'quantum sensor' selects individualised frequencies claimed to address a wide range of conditions.
Plausibility
Microcurrent delivery plausible at TENS level (cleared for pain only); the 'quantum sensor' frequency-individualisation contradicts established science.
Evidence — grade E
FDA 510(k) K191075 CLEARANCE (2019-10-30, Class II, 21 CFR 882.5890, TENS-for-pain predicate; product codes NUH/NYN; applicant TimeWaver Production GmbH) — a CLEARANCE, NOT an approval. The cleared indication is pain ONLY: temporary relief of muscle pain after exercise, symptomatic relief and management of chronic intractable pain, and relief of arthritis pain. The clearance covers that one indication under the TENS class and NOTHING else — not the frequency programmes, not any systemic or diagnostic claim. Australia registers it as an analgesic TENS system. (510(k) date is 2019-10-30 per the FDA primary source; the catalogue's 2019-11-22 is not used.)
Market
Makers: Healy World. Models: Healy (editions). Price: ~€500–2,000 by edition.
Kernel — keep vs set aside
Keep — real substrate
Real microcurrent hardware with a narrow, cleared analgesic indication (TENS-level).
Set aside — claim
The 'quantum sensor' frequency-individualisation contradicts established science and is outside the clearance. State it as clearance-with-scope (one indication — pain — under the TENS class), never as approval — the approval/clearance conflation is this product's principal marketing lever.
Regulatory status by jurisdiction
Registration or clearance is a market-access fact, never proof of efficacy.
US — FDA
510(k) K191075 CLEARANCE — Class II, 21 CFR 882.5890 (transcutaneous electrical nerve stimulator for pain relief), product codes NUH/NYN, applicant TimeWaver Production GmbH; decision 2019-10-30 (received 2019-11-12), substantial equivalence. CLEARANCE, not approval — cleared for ONE indication (pain) under the TENS class, nothing else.
EU — MDR
CE (device class); bioenergetic claims outside scope.
Russia
—
China — NMPA
—
Australia — TGA
Registered as an analgesic TENS system (ARTG); see enforcement note.